全文获取类型
收费全文 | 627篇 |
免费 | 25篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 28篇 |
妇产科学 | 8篇 |
基础医学 | 97篇 |
口腔科学 | 2篇 |
临床医学 | 49篇 |
内科学 | 106篇 |
皮肤病学 | 28篇 |
神经病学 | 17篇 |
特种医学 | 19篇 |
外科学 | 83篇 |
综合类 | 4篇 |
预防医学 | 144篇 |
眼科学 | 11篇 |
药学 | 28篇 |
肿瘤学 | 12篇 |
出版年
2023年 | 6篇 |
2022年 | 17篇 |
2021年 | 20篇 |
2020年 | 12篇 |
2019年 | 9篇 |
2018年 | 14篇 |
2017年 | 13篇 |
2016年 | 10篇 |
2015年 | 22篇 |
2014年 | 20篇 |
2013年 | 26篇 |
2012年 | 54篇 |
2011年 | 57篇 |
2010年 | 45篇 |
2009年 | 27篇 |
2008年 | 32篇 |
2007年 | 32篇 |
2006年 | 42篇 |
2005年 | 29篇 |
2004年 | 23篇 |
2003年 | 26篇 |
2002年 | 31篇 |
2001年 | 15篇 |
2000年 | 6篇 |
1999年 | 14篇 |
1998年 | 4篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1995年 | 2篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 7篇 |
1991年 | 6篇 |
1990年 | 7篇 |
1989年 | 4篇 |
1988年 | 3篇 |
1987年 | 2篇 |
1985年 | 1篇 |
1973年 | 3篇 |
1972年 | 3篇 |
排序方式: 共有652条查询结果,搜索用时 656 毫秒
1.
2.
3.
Ben Jemaa Z Mahjoubi F Ben Haj H'mida Y Hammami N Ben Ayed M Hammami A 《Pathologie-biologie》2004,52(2):82-88
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Sfax-Tunisia (1993-1998). The choice of antimicrobial therapy for the treatment of bacteremia is often empirical and based on the knowledge of susceptibility profiles of the most common bacteria causing such infections. This study determines the bacterial etiology of bacteremic episodes and antimicrobial susceptibility patterns recorded at a teaching hospital, from January 1993 to December 1998. We collected 2979 strains responsible for bacteremia. Gram negative bacteria were predominant (60%). The organisms recovered most frequently were Staphylococcus aureus (18.9%), Escherichia coli (14.7%), Klebsiella pneumoniae (14%) and Pseudomonas aeruginosa (7.6%). The incidence of resistance to methicillin were 17.4% for Staphylococcus aureus and 26.8% for coagulase negative Staphylococcus. No resistance to glycopeptides was observed among the enterococci and staphylococci studied. 27.7% of enterobacteriaceae were resistant to third generation cephalosporins. Imipenem was the most active agent against gram negative bacteria. To carry out a surveillance of bacteremic episodes occurring at every hospital, it is necessary to provide valuable information which should be the basis for effective empiric therapy. 相似文献
4.
A. Hammami G. Arlet S. Ben Redjeb F. Grimont A. Ben Hassen A. Rekik A. Philippon 《European journal of clinical microbiology & infectious diseases》1991,10(8):641-646
In a Tunisian hospital 27 babies, including 12 who were premature, in a single intensive care unit suffered acute gastroenteritis in the period from January to May 1988. The mean age at the onset of gastroenteritis was 8.4 days; nine babies died.Salmonella wien was isolated from stools (all babies) and blood (4 babies). It was also isolated from the stools of one nurse and from a mattress. Twelve of the babies had received cefotaxime, which was successfully replaced by oral colimycin. The outbreak was stopped by the implementation of infection control measures. All isolates ofSalmonella wien were of the same biotype, and had the same antibiotic resistance pattern (third generation cephalosporins, monobactams, aminoglycosides, chloramphenicol, trimethoprim and sulphonamides) and plasmid DNA restriction pattern. The isolates were all susceptible to a combination of cefotaxime and clavulanic acid (a -lactamase inhibitor), which displayed synergy, suggesting the presence of a -lactamase (geometric mean MICs 11.24 µg/ml for cefotaxime alone and 0.24 µg/ml in combination with 0.1 µg/ml potassium clavulanate). All isolates produced TEM-1 and SHV-2 -lactamase which was not transferable toEscherichia coli by conjugation. The presence of the SHV-2 enzyme inSalmonella wien may allow it to adapt to newer -lactams which is a cause for concern in this hospital. 相似文献
5.
6.
Human and equine rabies immunoglobulins are currently available for passive immunization against rabies. However, these are hampered by the limited supply and some drawbacks. Advances in antibody engineering have led to overcome issues of clinical applications and to improve the protective efficacy. In the present study, we report the generation of a trivalent single-chain Fv (scFv50AD1-Fd), that recognizes the rabies virus glycoprotein, genetically fused to the trimerization domain of the bacteriophage T4 fibritin, termed ‘foldon’ (Fd). scFv50AD1-Fd was expressed as soluble recombinant protein in bacterial periplasmic space and purified through affinity chromatography. The molecular integrity and stability were analyzed by polyacrylamide gradient-gel electrophoresis, size-exclusion chromatography and incubation in human sera. The antigen-binding properties of the trimeric scFv were analyzed by direct and competitive-ELISA. Its apparent affinity constant was estimated at 1.4 ± 0.25 × 109 M−1 and was 75-fold higher than its monovalent scFv (1.9 ± 0.68 × 107 M−1). The scFv50AD1-Fd neutralized rabies virus in a standard in vitro and in vivo neutralization assay. We showed a high neutralization activity up to 75-fold compared with monovalent format and the WHO standard serum. The gain in avidity resulting from multivalency along with an improved biological activity makes the trivalent scFv50AD1-Fd construct an important reagent for rabies protection. The antibody engineering approach presented here may serve as a strategy for designing a new generation of anti-rabies for passive immunotherapy. 相似文献
7.
8.
9.
10.
Muhammad?M.?HammamiEmail author Eman?Al Gaai Safa?Hammami Sahar?Attala 《BMC palliative care》2015,14(1):66